Skip to main content
. 2023 Sep 15;15(10):5454–5465. doi: 10.21037/jtd-22-1669

Figure 6.

Figure 6

Effect of UCMNCs on CD4/CD8 lymphocyte subsets in BALF of mice with OVA-induced asthma. (A) CD4/CD8 lymphocyte cells were gating from CD3+CD45+ cells using flow cytometry. (B) Effect of UCMNCs on CD4/CD8 lymphocyte subsets in BALF. Data are expressed as mean ± standard deviation. ##, P<0.01 vs. control group; *, P<0.05, **, P<0.01 vs. model group; n=5. UCMNCL, UCMNCM, and UCMNCH: intravenous injection of 4×105, 2×106, and 107 UCMNCs per mouse, respectively; FMMNC: intravenous injection of 2×106 FMMNCs per mouse. IL, interleukin; DEX, dexamethasone; UCMNC, umbilical cord blood mononuclear cell; UCMNCL, low-dose UCMNC; UCMNCM, medium-dose UCMNC; UCMNCH, high-dose UCMNC; FMMNC, fetal mouse blood mononuclear cell; BALF, bronchoalveolar lavage fluid; OVA, ovalbumin.